An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus (SLE) Intervention: Drug: anti-CD19 CAR NK cells (KN5501) Sponsors: Changhai Hospital; Nanjing Enricnk Biotech Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials